### gof
| **PCSK9** | **Genetic loci** | **Amino acid change**           | **Gene function**   | **Traits associated with this variant**                                              | **reference** |
|-----------|-----------------|----------------------------------|---------------------|------------------------------------------------------------------------------|-------------|
| PCSK9     | rs28942071      | p.D374Y                          | Gain of function    | Autosomal dominant hypercholesterolemia, increased risk of atherosclerosis    | [1], [3]    |
| PCSK9     | rs2746352       | p.S127R                          | Gain of function    | Familial hypercholesterolemia, higher circulating LDL-C and increased CVD risk| [2], [4]    |
| PCSK9     | rs72646508      | p.R499H                          | Gain of function    | Familial hypercholesterolemia, degradation of LDL receptors                   | [5], [6]    |

### References:
[1] URL: https://www.ahajournals.org/doi/10.1161/atvbaha.116.307613  
    Quoted sentence: "Two groups have studied effects of a well-characterized gain-of-function mutation in humans, D374Y, on atherosclerosis in mice using adeno-..." 

[2] URL: https://www.atherosclerosis-journal.com/article/S0021-9150(24)01168-7/fulltext  
    Quoted sentence: "Muller, P.Y.. Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples? Atherosclerosis. 2000; 148:433-436."

[3] URL: https://www.nature.com/articles/s41598-025-91061-5   
    Quoted sentence: "Administration of fenofibrate can effectively suppress expansion of the atherosclerotic plaque area and inflammatory changes caused by the D374Y mutation."

[4] URL: https://www.ncbi.nlm.nih.gov/gene/255738  
    Quoted sentence: "...PCSK9 expression is associated with atherosclerosis... Gain-of-function mutations in PCSK9 found to cause familial hypercholesterolemia, loss-"

[5] URL: https://www.sciencedirect.com/science/article/abs/pii/S0021915019314650  
    Quoted sentence: "GOF mutations in the PCSK9 gene are a minor cause of FH, representing less than 1% of cases, with approximately 30 variants described so far [8]."

[6] URL: https://www.mdpi.com/2227-9717/9/2/283  
    Quoted sentence: "The gain-of-function (GOF) mutations aggravate the degradation of LDL receptors, resulting in familial hypercholesterolemia (FH), while loss-of-function mutations reduce the risk."
